Jack Ma-Backed Ant Bets on AI Health in $69 Billion Sector Race

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Roughly five years ago, Ant Group Co. reined in its ambitions after a derailed initial public offering. Today, the Jack Ma-backed company is betting on a very different business to fuel its next phase of growth: health care powered by artificial intelligence.What began as a digital payments platform has become one of China’s biggest investors in medical AI, backing software that fields patient questions and connects them with doctors, pharmacies and insurers. In November, Ant elevated its health unit to the same level as operations including Alipay and its lending businesses, underscoring how central the effort has become to the company’s strategy.